» Articles » PMID: 33995009

Biophysical Compatibility of a Heterotrimeric Tyrosinase-TYRP1-TYRP2 Metalloenzyme Complex

Overview
Journal Front Pharmacol
Date 2021 May 17
PMID 33995009
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Tyrosinase (TYR) is a copper-containing monooxygenase central to the function of melanocytes. Alterations in its expression or activity contribute to variations in skin, hair and eye color, and underlie a variety of pathogenic pigmentary phenotypes, including several forms of oculocutaneous albinism (OCA). Many of these phenotypes are linked to individual missense mutations causing single nucleotide variants and polymorphisms (SNVs) in . We previously showed that two TYR homologues, TYRP1 and TYRP2, modulate TYR activity and stabilize the TYR protein. Accordingly, to investigate whether TYR, TYRP1, and TYRP2 are biophysically compatible with various heterocomplexes, we computationally docked a high-quality 3D model of TYR to the crystal structure of TYRP1 and to a high-quality 3D model of TYRP2. Remarkably, the resulting TYR-TYRP1 heterodimer was complementary in structure and energy with the TYR-TYRP2 heterodimer, with TYRP1 and TYRP2 docking to different adjacent surfaces on TYR that apposed a third realistic protein interface between TYRP1-TYRP2. Hence, the 3D models are compatible with a heterotrimeric TYR-TYRP1-TYRP2 complex. In addition, this heterotrimeric TYR-TYRP1-TYRP2 positioned the C-terminus of each folded enzymatic domain in an ideal position to allow their C-terminal transmembrane helices to form a putative membrane embedded three-helix bundle. Finally, pathogenic mutations causing OCA1A, which also destabilize TYR biochemically, cluster on an unoccupied protein interface at the periphery of the heterotrimeric complex, suggesting that this may be a docking site for OCA2, an anion channel. Pathogenic mutations result in similar phenotypes to those produced by OCA1A mutations. While this complex may be difficult to detect , due to the complex environment of the vertebrate cellular membranous system, our results support the existence of a heterotrimeric complex in melanogenesis.

Citing Articles

Drug Repurposing of Voglibose, a Diabetes Medication for Skin Health.

Kim H, Hyun C Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40006038 PMC: 11859330. DOI: 10.3390/ph18020224.


Establishment of a synchronized tyrosinase transport system revealed a role of Tyrp1 in efficient melanogenesis by promoting tyrosinase targeting to melanosomes.

Nakamura H, Fukuda M Sci Rep. 2024; 14(1):2529.

PMID: 38291221 PMC: 10827793. DOI: 10.1038/s41598-024-53072-6.


Phenolic acids in inhibit melanin production through bidirectional regulation of melanin synthase transcription via different signaling pathways.

Liu J, Xu X, Zhou J, Sun G, Li Z, Zhai L J Ginseng Res. 2023; 47(6):714-725.

PMID: 38107393 PMC: 10721457. DOI: 10.1016/j.jgr.2023.05.002.


Genetic variants in melanogenesis proteins TYRP1 and TYR are associated with the golden rhesus macaque phenotype.

Peterson S, Watowich M, Renner L, Martin S, Offenberg E, Lea A G3 (Bethesda). 2023; 13(10).

PMID: 37522525 PMC: 10542561. DOI: 10.1093/g3journal/jkad168.


The Mouse Model to Unravel Retinogenesis Misregulation in Patients with Albinism.

Tingaud-Sequeira A, Mercier E, Michaud V, Pinson B, Gazova I, Gontier E Genes (Basel). 2022; 13(7).

PMID: 35885947 PMC: 9324463. DOI: 10.3390/genes13071164.


References
1.
Martinez-Ortiz W, Cardozo T . An Improved Method for Modeling Voltage-Gated Ion Channels at Atomic Accuracy Applied to Human Ca Channels. Cell Rep. 2018; 23(5):1399-1408. PMC: 5957504. DOI: 10.1016/j.celrep.2018.04.024. View

2.
Dolinska M, Young 2nd K, Kassouf C, Dimitriadis E, Wingfield P, Sergeev Y . Protein Stability and Functional Characterization of Intra-Melanosomal Domain of Human Recombinant Tyrosinase-Related Protein 1. Int J Mol Sci. 2020; 21(1). PMC: 6981619. DOI: 10.3390/ijms21010331. View

3.
Sweetlove L, Fernie A . The role of dynamic enzyme assemblies and substrate channelling in metabolic regulation. Nat Commun. 2018; 9(1):2136. PMC: 5976638. DOI: 10.1038/s41467-018-04543-8. View

4.
Toyofuku K, Wada I, Valencia J, Kushimoto T, Ferrans V, Hearing V . Oculocutaneous albinism types 1 and 3 are ER retention diseases: mutation of tyrosinase or Tyrp1 can affect the processing of both mutant and wild-type proteins. FASEB J. 2001; 15(12):2149-61. DOI: 10.1096/fj.01-0216com. View

5.
Lai X, Wichers H, Soler-Lopez M, Dijkstra B . Structure of Human Tyrosinase Related Protein 1 Reveals a Binuclear Zinc Active Site Important for Melanogenesis. Angew Chem Int Ed Engl. 2017; 56(33):9812-9815. PMC: 5601231. DOI: 10.1002/anie.201704616. View